The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.72
Bid: 42.66
Ask: 42.78
Change: 0.12 (0.28%)
Spread: 0.12 (0.281%)
Open: 42.26
High: 42.94
Low: 42.26
Prev. Close: 42.60
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

6 Jul 2023 14:47

RNS Number : 2417F
Assura PLC
06 July 2023
 

6 July 2023

Assura plc ("Company")

Result of AGM

 

Assura plc announces that at its Annual General Meeting held earlier today, each of the resolutions submitted to the meeting (as set out in the Notice of the Meeting dated 2 June 2023) were passed by the requisite majorities on a poll.

Resolution

For

%

For

Against

% Against

Total Votes Cast (% of issued share capital)

Votes Withheld

1. To receive the Company's report and accounts

2,404,255,196

99.93

1,633,381

0.07

2,405,888,577(81.18)

1,591,592

2. To approve the Directors' Remuneration Report

2,341,833,957

97.77

53,533,946

2.23

2,395,367,903 (80.82)

12,112,266

3. To re-appoint Ernst & Young LLP as auditor of the Company 

2,405,682,727

99.93

1,747,896

0.07

2,407,430,623 (81.23)

49,546

4. To authorise the Audit Committee to determine the auditor's remuneration 

2,407,370,213

99.99

86,743

0.00

2,407,456,956 (81.23)

23,213

5. To re-elect Ed Smith as a Director of the Company

2,233,952,170

95.20

112,717,776

4.80

2,346,669,946 (79.18)

60,810,223

6. To re-elect Louise Fowler as a Director of the Company

2,383,530,756

99.01

23,915,485

0.99

2,407,446,241 (81.23)

33,928

7. To re-elect Jonathan Murphy as a Director of the Company

2,399,732,255

99.68

7,711,891

0.32

2,407,444,146 (81.23)

36,023

8. To re-elect Jayne Cottam as a Director of the Company

2,375,836,492

98.69

31,610,664

1.31

2,407,447,156 (81.23)

33,013

9. To re-elect Jonathan Davies as a Director of the Company

2,384,867,137

99.06

22,576,095

0.94

2,407,443,232 (81.23)

36,937

10. To re-elect Sam Barrell as a Director of the Company

2,384,892,936

99.06

22,550,296

0.94

2,407,443,232 (81.23)

36,937

11. To re-elect Emma Cariaga as a Director of the Company

2,406,157,355

99.95

1,285,877

0.05

2,407,443,232 (81.23)

36,937

12. To re-elect Noel Gordon as a Director of the Company

2,387,372,443

99.17

20,070,789

0.83

2,407,443,232 (81.23)

36,937

13. To authorise the Directors to allot shares

2,298,635,357

95.54

107,364,047

4.46

2,405,999,404 (81.18)

1,480,765

14. To empower the Directors to disapply pre-emption rights

2,377,573,799

98.82

28,407,039

1.18

2,405,980,838(81.18)

1,499,331

15. To empower the Directors to disapply pre-emption rights in connection with an acquisition or specified capital investment

2,295,995,741

95.62

105,215,996

4.38

2,401,211,737 (81.02)

6,268,432

16. To authorise the market purchase of the Company's own shares

2,405,270,604

99.99

290,670

0.01

2,405,561,274(81.17)

1,918,895

17. To authorise the Company to call any general meeting, other than the Annual General Meeting, by not less than 14 clear days' notice

2,277,947,643

94.62

129,482,515

5.38

2,407,430,158 (81.23)

50,011

Resolutions 1-13 were passed as ordinary resolutions. Resolutions 14-17 were passed as special resolutions. Votes 'For' include votes at the discretion of the Chairman. 

Notes:

1. The percentages above are rounded to two decimal places.

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

3. The number of ordinary shares in issue on the share register at 6.00pm on 5 July 2023 was 2,963,648,116 of which the Total Voting Rights figure was 2,963,648,116.

Copies of resolutions 14-17, being resolutions other than resolutions concerning ordinary business passed by the Company at the above AGM, have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

- Ends -

For more information, please contact:

 

Assura plc

 

Tel: 01925 945354

Orla Ball, General Counsel

David Purcell, Investor Relations Director

 

Email: Investor@assura.co.uk

FGS Global

Gordon SimpsonJames Thompson

Tel: 0207 251 3801

Email: Assura@fgsglobal.com

 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

 

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at £2.7 billion.

 

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

Assura plc LEI code: 21380026T19N2Y52XF72

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSSEFDMEDSELW
Date   Source Headline
10th Nov 202011:54 amRNSDirector/PDMR Shareholding
5th Nov 20209:52 amRNSNotice of Interim Results
4th Nov 20207:00 amRNSIssue of Consideration Shares
22nd Oct 20204:48 pmRNSHolding(s) in Company
19th Oct 202012:13 pmRNSDirector/PDMR Shareholding
12th Oct 20204:54 pmRNSScrip Dividend Declaration
7th Oct 202012:11 pmRNSDirector/PDMR Shareholding
7th Oct 202012:05 pmRNSCorrection to Trading Update
7th Oct 20207:00 amRNSTrading Update
25th Sep 20201:50 pmRNSHolding(s) in Company
23rd Sep 202012:07 pmRNSDirector/PDMR Shareholding
17th Sep 202010:30 amRNSScrip Calculation Price
16th Sep 20207:00 amRNSVirtual Property Tour
8th Sep 20204:19 pmRNSPricing of £300m Social Bond
4th Sep 20202:36 pmRNSDirector/PDMR Shareholding
4th Sep 20202:34 pmRNSAdditional Listing
3rd Sep 20201:31 pmRNSNotice of Dividend
20th Aug 20203:02 pmRNSNotification of Major Interests in Shares
3rd Aug 202011:11 amRNSDirector/PDMR Shareholding
24th Jul 20203:04 pmRNSExercise of Nil Cost Options under PSP
21st Jul 20207:00 amRNSAdditional Listing
16th Jul 20207:00 amRNSDirector/PDMR Shareholding
14th Jul 202012:54 pmRNSPDMR Notification
9th Jul 20207:00 amRNSScrip Dividend Declaration
8th Jul 20201:42 pmRNSNotification of Major Interests in Shares
7th Jul 20203:12 pmRNSResult of AGM
7th Jul 20207:00 amRNSTrading update
1st Jul 20201:25 pmRNSNotification of Major Interests in Shares
24th Jun 20208:00 amRNSNotification of Major Interests in Shares
18th Jun 20202:43 pmRNSScrip Calculation Price
15th Jun 20205:15 pmRNSNotification of Major Interests in Shares
12th Jun 20203:54 pmRNSDirector/PDMR Shareholding
12th Jun 202011:47 amRNSAmended Notice of AGM
9th Jun 20202:04 pmRNSAnnual Report and Notice of AGM
4th Jun 202010:01 amRNSNotice of dividend
21st May 20207:00 amRNSAssura Full Year Results
11th May 20207:00 amRNSConfirmation of announcement date for results
16th Apr 202010:50 amRNSDirector/PDMR Shareholding
14th Apr 202012:38 pmRNSReplacement Scrip Dividend Declaration
14th Apr 20207:00 amRNSNotification of Major Interests in Shares
14th Apr 20207:00 amRNSNotification of Major Interests in Shares
9th Apr 20207:00 amRNSScrip Dividend Declaration
7th Apr 20207:00 amRNSResults of Placing
6th Apr 20204:42 pmRNSProposed equity placing of new ordinary shares
2nd Apr 20207:00 amRNSTrading update
20th Mar 20207:00 amRNSScrip Calculation Price
13th Mar 20204:46 pmRNSNotification of Major Interests in Shares
5th Mar 20207:00 amRNSNotice of Dividend
24th Feb 20203:40 pmRNSNotification of Major Interests in Shares
20th Feb 20209:13 amRNSNotification of Major Interests in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.